Value-based care was supposed to reshape how O&P gets paid. The O&P EDGE says it hasn't.

An industry trade publication for orthotics and prosthetics practitioners published an analysis this week with an interesting headline: Value-Based Care Is Not Taking Over. The piece is written as a follow-up to earlier coverage that argued O&P practices needed to prepare for a coming shift in how care gets paid for. The update, roughly: that shift hasn’t arrived on schedule, and may not arrive the way the field expected.

For people whose prostheses, orthotics, and related supplies move through insurance systems, this is worth understanding — not because it changes anything about your coverage today, but because it names something real about why the system works the way it does.

What the two payment models actually mean

Healthcare providers in the United States are paid under different models depending on the payer, the service, and the contract. The two broad categories that come up in O&P:

Fee-for-service is the default in most of Medicare and most private insurance. A practitioner bills a code for a specific device, component, or service, and the payer reimburses a set amount for that item. The volume of services delivered determines the revenue. Whether the patient walked farther or felt less pain after the fitting is not a direct factor in whether or how much the clinic gets paid for the work.

Value-based care is a category of payment models that try to change that. Instead of paying per item delivered, a payer agrees to pay based on whether certain outcomes are achieved — or holds back a portion of payment and returns it if a practice meets performance targets. Accountable care organizations, bundled payments, and pay-for-performance arrangements are all variations on this framework. The idea is to align the financial incentives of providers with the outcomes patients actually care about.

In theory, a well-designed value-based O&P arrangement would pay a practice more if a patient’s functional mobility improved — and less if the device sat unused. In practice, building those systems is harder than announcing them.

Why VBC has moved slowly in O&P

The O&P field has structural characteristics that complicate value-based payment. The O&P EDGE has been tracking the argument that practices need to get ahead of the shift: measure functional outcomes systematically, document the relationship between devices and patient function, and be able to demonstrate cost-effectiveness in a way that health systems and payers can evaluate. That is reasonable preparation for a future where payers demand that data.

What the new analysis adds is that the future has arrived more slowly than projected. Fee-for-service continues to govern the large majority of O&P reimbursement in Medicare and most commercial insurance. The payment reform wave that reshaped parts of primary care, hospital care, and some specialty sectors has not swept through O&P at the expected pace.

Several reasons account for this. O&P is a relatively small market within the broader healthcare billing universe — it lacks the volume that makes outcome-based contracts attractive to large payers building model infrastructure. The devices involved are individualized, which makes standardized outcome benchmarks harder to define than in, say, hip replacement or cardiac care. And small O&P practices — which describe a significant portion of the field — often lack the data systems and administrative infrastructure that VBC contracts tend to require.

None of this means value-based care is irrelevant to O&P. It means the shift is happening at the margins: in some hospital systems, in pilot programs, in certain ACO arrangements. It is not yet the dominant payment environment.

What this means at the appointment level

For people receiving prosthetics or orthotics, the practical implications are what fee-for-service always produces:

The system pays for what your provider bills. That means what you receive, what is covered, and what costs you out of pocket are governed by the codes your clinic submits, the coverage rules of your specific plan or Medicare contract, and the documentation supporting each claim. Functional outcome — how well the device works for your life — factors into payment only to the extent that your plan or Medicare requires functional assessment documentation before authorizing certain device levels or components.

This is why coverage disputes in O&P so often look like documentation disputes. A payer is not directly measuring whether someone can walk across a parking lot after a fitting. It is evaluating whether the submitted records demonstrate that the patient meets the clinical criteria for the device that was billed. The gap between those two questions is where a lot of access problems live.

A world with more value-based payment in O&P would ideally narrow that gap — if functional outcomes are what generate reimbursement, practitioners have a financial incentive to measure and document them rigorously. Whether better-designed payment models would actually improve patient outcomes or just shift the documentation burden is a legitimate question that the O&P EDGE analysis does not fully resolve.

The next useful question

O&P trade analysis about payment models is written primarily for practitioners. The question most useful for patients is simpler: who benefits when the current system is working, and who gets left behind when it is not?

Fee-for-service covers devices and services that meet billing criteria. Patients whose documentation supports what they need generally move through the system. Patients whose conditions, function, or coverage circumstances fall between the billing categories have a harder time. That problem does not disappear if value-based care eventually arrives — it might shift to a new set of edges — but the current system concentrates it around documentation, coding, and the number of enrolled providers willing to work in specific markets.

The moratorium on new DMEPOS supplier enrollment, which we covered recently, sits in exactly this gap. The payment model cannot help patients in areas where there are no enrolled providers to bill under it. A future where value-based care expands in O&P does not solve that problem either, unless the contracts are designed with geographic access in mind — something the O&P EDGE analysis does not address.

For now: your O&P care runs on fee-for-service, almost certainly. Understanding that system — what your payer covers, what documentation your clinic needs, and what to ask when a claim is delayed or denied — is the durable practical knowledge, regardless of where the payment model debate lands.

---

Amputee News does not provide individualized insurance, billing, or coverage advice. Medicare and commercial insurance coverage for prosthetics and orthotics depends on applicable coverage rules, documentation, functional assessment, and claim-specific factors. For help understanding your coverage or a coverage decision, contact your plan directly, call 1-800-MEDICARE for Medicare questions, or reach a State Health Insurance Assistance Program (SHIP) counselor at no cost.